Clinical Trial Update: Clinnova-IBD, a Prospective Cohort of Patients With Inflammatory Bowel Disease (IBD)

View source ↗

Summary

Clinnova-IBD is a prospective cohort study by the Luxembourg Institute of Health focusing on inflammatory bowel disease, currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Snippet

Sponsor: Luxembourg Institute of Health | Conditions: Inflammatory Bowel Diseases | Status: RECRUITING